Soleus Capital Management’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCT
Soleus Capital Management's NVCT Position: Q3 2026 in Review
Soleus Capital Management increased its Nuvectis Pharma (NVCT) stake by 71% in Q3 2026, buying an estimated $15M and bringing the position to 1,710,658 shares worth $36.1M. The position accounts for 1.28% of the portfolio, ranked #22.
Soleus Capital Management first reported a position in NVCT in Q2 2026 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.
- Soleus Capital Management held 1,710,658 shares of Nuvectis Pharma worth $36.1M as of Q3 2026.
- Soleus Capital Management bought 710,658 Nuvectis Pharma shares in Q3 2026, an estimated $15M.
- Nuvectis Pharma made up 1.28% of Soleus Capital Management's portfolio in Q3 2026, its #22 holding.
- Soleus Capital Management first reported a position in Nuvectis Pharma in Q2 2026 and has held it in 2 quarters since.
- 95 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.
Based on Soleus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.